13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-15, with 22 holding rows worth $706,509,000.
- Accession
- 0001085146-16-004292
- Filer
- CIK 1544773
- Filed
- 2016-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2016
A holdings report, 22 entries on the cover page, a total value of $706,509,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $706,509,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Mallinckrodt Plc | G5785G107 | SHS | 1,560,157 | $94,826,000 | thousands by filing date | |
| MEDIVATION INC | 58501N101 | COM | 1,270,000 | $76,581,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 8,845,742 | $65,370,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 4,929,139 | $64,448,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 1,224,496 | $51,919,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 2,699,947 | $48,086,000 | thousands by filing date | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 817,456 | $45,630,000 | thousands by filing date | |
| DEPOMED INC | 249908104 | COM | 2,275,300 | $44,641,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 418,700 | $44,349,000 | thousands by filing date | |
| PENUMBRA INC COM | 70975L107 | Stock | 684,079 | $40,703,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 2,936,487 | $40,289,000 | thousands by filing date | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 482,047 | $18,699,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 835,134 | $18,106,000 | thousands by filing date | |
| CEPHEID | 15670R107 | COM | 453,662 | $13,950,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 165,203 | $9,866,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 1,114,448 | $7,840,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,273,933 | $7,580,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 2,232,940 | $5,024,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 526,351 | $3,621,000 | thousands by filing date | |
| SEASPINE HLDGS CORP | 81255T108 | COM | 255,334 | $2,676,000 | thousands by filing date | |
| BIOLASE INC | 090911108 | COMMON STOCK | 1,257,292 | $1,471,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 165,825 | $834,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-16-004292 | this filing | 2016-08-15 | acceptance time not in the bulk data set |